Status: current, Defined. Date: 30-Nov 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4755721000168110 | CDA CBD (cannabidiol 33.33 mg) capsule, 30 capsules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4755731000168113 | CDA CBD 33.33 mg capsule, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| CDA CBD 33.33 mg capsule, 30 | Is a | cannabidiol 33.33 mg capsule, 30 | true | Inferred relationship | Some | ||
| CDA CBD 33.33 mg capsule, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| CDA CBD 33.33 mg capsule, 30 | has TP | CDA CBD | true | Inferred relationship | Some | ||
| CDA CBD 33.33 mg capsule, 30 | has TPUU | CDA CBD 33.33 mg capsule | true | Inferred relationship | Some | 595904249 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| CDA CBD 33.33 mg capsule, 30, bottle | Is a | True | CDA CBD 33.33 mg capsule, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR